Смекни!
smekni.com

Сравнительный анализ структуры наследственной компоненты подверженности к бронхиальной астме и т (стр. 21 из 22)

184. Matsushita I., Hasegawa K., Nakata K. et al. Genetics Variants of Human b-Defensin-1 and Chronic Obstructive Pulmonary Disease // Biochemical and Biophysical Research Communications. – 2002. – V. 291. – P. 17-22.

185. Melen E., Bruce S., Doekes G. et al. Haplotypes of G-protein-coupled Receptor 154 are Associated with Childhood Allergy and Asthma // Am. J. Respir. Crit. Care Med. – 2005. – V. 121. – P. 1089-1095.

186. Meyer C.G., May J., Stark K. Human Leukocyte antigens in tuberculosis and leprosy // Trends Microbiol. – 1998. - V. 6. - № 4. – P. 148-154.

187. Miller D.P., Liu G., De Vivo I. et al. Combinations of the variant genotypes of GSTP1, GSTM1 and p53 are associated with an increased lung cancer risk // Cancer Research. – 2002. - V. 62. – P. 2819-2823.

188. Mitsuyasu H., Izuhara K., Mao X.Q. et al. Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma // Nat. Genet. – 1998. - № 19. – P. 119-120.

189. Moffatt M. F., Cookson W. O. Tumor necrosis factor haplotypes and asthma // Human Molecular Genet. – 1997. – V. 6. – P. 551-554.

190. Moffatt M. F., Schou C., Faux J. A. et al. Germline TCR-A restriction of immunoglobulin E responses to allergen // Immunogenetics. – 1997. - № 46. – P. 226-230.

191. Morgenstern R., DePierre J. W. Microsomal glutathione S-transferase // Rev. Biochem. Toxicol. - 1985. – V. 7. – P. 67-103.

192. Morita S., Yano M., Shiozaki et al. CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamouscell carcinoma of the esophagus // Int. J. Cancer. – 1997. – V. 71. – P. 192-195.

193. Munaka M., Kohshi K., Kawamoto T et al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hapatocellular carcinoma // Journal of cancer research and clinical oncology. – 2003. - V. 129. – №. 6. - P. 355-360.

194. Mutmansky J.M. The war on black lung // Earth and Miner. Sci. – 1990. – V. 59. – P. 6-10.

195. Nanavaty U., Goldstein A.D., Levine S.J. Polymorphisms in candidate asthma genes // Am. J. Med. Sci. – 2001. – V. 321. – P. 11-16.

196. Nebert D. W., Jorge-Nebert L., Vesell E. S. Pharmacogenomics and “Individualized drug therapy” // Am. J. Pharmacogenomics. – 2003. – V. 3. - № 6. – P. 361-370.

197. Nebert D.W. Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? // Am. J. Hum. Genet. – 1997. - № 60. – P. 265-271.

198. Nelson D. R., Koymans L., Kamataki T. et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature // Pharmacogenetics. – 1996. – V. 6. – P. 1-42.

199. Nickel R. G., Casolaro V., Wahn U. et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES // J. Immunol. – 2000. - № 164. – P. 1612-1616.

200. Nicolae D., Cox N.J., Lester L. et al. A fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21 // Am. J. Hum. Genet. – 2005. – V. 76. - № 2. – P. - 349-57.

201. Nieminen M. M., Kaprio J., Koskenvuo M. A population-based study of bronchial asthma in adult twin pairs // Chest. – 1991. – V. 100. – P. 70-75.

202. Noguchi E., Shibasaki M., Arinami T. et al. Assotiation of asthma and the interleukin-4 promoter gene in Japanese // Clin Exp Allergy. – 1998. – 28. – P. 449-453.

203. North R .J., Medina E. How important is Nramp1 in tuberculosis? // Trends in Microbiology. – 1998. – V. 6. - №11. – P. 441-443.

204. Obase Y., Shimoda T., Kawano T. et al. Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma // Clin Pharmacol Ther. – 2003. – V. 73. - № 5. – P. 468-474.

205. Ober C., Cox N. J., Abney M. et al. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma // Hum. Mol. Genet. – 1998. – V. 7. - P1393-1398.

206. Ober S., Leavitt S. A., Tsaienko A. et al., Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations // Am. J. Hum. Genet. – 2000. - № 66. – P. 517-526.

207. Organov R.G., Maslennikova G. Ya. // Eur. Respir. J. – 1999. – V. 13. - № 2. – P. 287- 289.

208. Paigen K.and Eppig J. T. A mouse phenome project / Mamm. Genome. – 2000. – V. 11. - № 9. – P. 715-717.

209. Park J.Y., Schantz S.P., Stern J.C. et al., Assotiation between glutathione S-transferase pi genetic polymorphism and oral cancer risk // Pharmacogenerics. – 2000. - V. 10. - № 4. – P. 374.

210. Pearce N. What does the odds ratio estimate in a case-control study? // Int. J. Epidemiol. – 1993. – V. 26 № 6. – P. 1189-1192.

211. Pelkonen O., Raunio H. Metabolic activation of toxins: tissue-specific expression and metabolism in target organs // Environ. Health Perspect. – 1997. – V. 105. – Suppl. 4. – P. 767-774.

212. Pemble S., Schroeder K.R., Spencer S.R. et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism // Biochem J. – 1994. – V. 300. – P. 271-276.

213. Pillai S. G, Cousens D. J, Barnes A. A. A coding polymorphism in the CYSLT2 receptor with reduced affinity to LTD4 is associated with asthma // Pharmacogenetics. – 2004. – V. 14. - № 9. – P. - 627-633.

214. Poland A., Glover E., Robinson J. R. et al. Genetic expression of aryl hydrocarbon hydroxylase activity, induction of monooxygenase activities and cytochrome P450 formation by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in mice genetically “non-resposive” to others aromatic hydrocarbons // J. Biol. Chem. – 1973. – V. 249. – P. 5599-5606.

215. Prandota J. Important role of prodromal viral infection responsible for inhibition of xenobiotic metabolizing enzymes in the pathomechanism of idiopathic Reye’s syndrome, Stevens-Johanson syndrome, autoimmune hepatits and hepatotoxicity of therapeutic doses of acetaminophen used in genetically predposed persos // Am. J. Ther. – 2002. – V. 9. – P. 149-156.

216. Pykalainen M, Kinos R, Valkonen S. et al. Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes // J. Allergy Clin. Immunol. – 2005. – V. 115. - № 1. – P. - 80-87.

217. Quanjer P.H., Tammeling G.L., Cotes J.E. et al. Lung volumes and ventilatory flows // Eur. Respir. J. – 1993. – V. 6. – P. 4-40.

218. Ramsey C.D., Lazarus R., Camargo C.A. et al. Polymorphisms in the interleukin 17F gene (IL17F) and asthma // Genes Immun. – 2005. – V. 6. - № 3. – P. 236-241.

219. Raunio H., Husgafvel-Pursianen, Anttila S. et al. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility – a review // Gene. – 1995. – V. 159. – P. 113-121.

220. Ravindranath V. Metabolism of xenobiotics in the central nervous system: implications and challenges // Biochem. Pharmacol. – 1998. – V. 56. – P. 547-551.

221. Reihsaus E., Innis M., Macintyre N. et al. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects // Am. J. Respir. Cell Mol. Biol. – 1993. – V. 8. – P. 334 -339.

222. Renton K.W. Cytochrome P450 regulation and drug biotransformation during inflammation and infection // Curr Drug Metab. – 2004. - V. 5. № 3. – P. 235-243.

223. Richardson T.H., Jung F., Griffin K.J. et al. A universal approach to the expression of human and rabbit cytochrome P450s of the 2C subfamily in Escherichia coli // Arch. Biochem. Biophys. – 1995. – V. 323. - № 1. – P. 87-96.

224. Richter-Hintz D., Their R., Steinwachs S. et al. Allelic variants of drug metabolizing enzymes as risk factors in psoriasis // Journal of Investigative Dermatology. – 2003. - V. 120. – P. 765-770.

225. Rifkind A. B., Lee C., Chang T. K. and Waxman D. J. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes // Arch Biochem Biophys. –1995. – V. 320. - № 3. – P. 380-389.

226. Rollinson S., Levene A. P., Mensah F. K., Roddam P. L. et al. Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity // Blood. – 2003. - V. 102. - № 3. – P. 1007-1011.

227. Romkes M., Faletto M.B., Blaisdell I.A. et al. Cloning and expression of the complementary DNAs for multiple members of the human cytochrome P450IIC subfamily // Biochemistry. – 1991. – V. 30. № 13. – P. 3247-55.

228. Rosenwasser L. J., Klemm D. J., Dresback J. K. et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy // Clin. Exp. Allergy. – 1995. - № 25 (suppl 2). – P. 74-78.

229. Roy B., Chowdhury A., Kundu S. et al. Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 “null” mutation // Journal of Gastroenterology and Hepatology. – 2001. – V. 16. – P. 1033-1037.

230. Ryu S., Park Y.-K., Bai G. H. et al. 3’ UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans // Int. J. Tuberc. Lung. Dis. – 2000. – V. 4. - № 6. – P. 577-580.

231. Saito K. Shinoharaet A., Kamataki T. et al. N-hydroxylanine O-acetyltransferase in hamster liver: identity with arylhydroxamic acid N,O-acetyltransferase and arylamine N- acetyltransferase // J. Biochem. – 1986. – V. 99. - № 6. – P. 1689-1697.

232. Salama S. A., Sierra-Torres C. H., Oh H-Y. et al. A multiplex-PCR/RFLP procedure for simultaneous CYP2E1, mEH and GSTM1 genotyping // Cancer Lett. – 1999. – V. 143. – P. 51-56.

233. Sandford A. J., Silverman E. K. Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction // Thorax. – 2002. – V. 57. - № 8. - P. 736-741.

234. Sandford A.J., Weir T.D., Pare P.D. et al. State of the Art. The genetics of asthma // Am. J. Respir. Crit. Care Med. – 1996. – V. 13. – P. 1749-1765.

235. Schwab M., Schaeffeler E., Klotz U. et al. CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori // Clin Pharmacol Ther. – 2004. – V. 76. – P.201-209.

236. Schwartz D.A., Freedman J.H. and Linney E.A. Environmental genomics; a key to understanding biology, pathophysiology and disease // Hum. Mol. Genet. – 2004. – V. 13. – P. 217-224.

237. Seidegard J., Vorachek W.R., Pero R.W. et al. Hereditary differences in the expression of human glutathione transferase activity on trans-stilbene oxide are due to a gene deletion // Proc. Nat. Acad. Sci. USA. – 1988. – V. 85. – P. 7293-7297.

238. Senak M., Pierzchalska M., Bazan-Socha S. et al. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma // Am. J. Respir. Cell Mol. Biol. – 2000. - № 23. – P. 290-296.

239. Sengler C. Lau S., Wan U. et al. Interactions between genes and environmental factors in asthma and atopy: new developments // Respir. Res. – 2002. – V. 3. № 7. – P. 7.

240. Shields P.G., Caporaso N.E., Falk R.T. et al. Lung cancer, race and CYP1A1 genetic polymorphism // Cancer Epidemiol. Biomarkers and Prev. – 1993. - № 2 – P. 481-485.

241. Shirakawa T., Enomoto T., Shimazu S. et al. The inverse assotiation between tuberculin responses and atopic disorder // Science. – 1997. – V. 275. – P. 77-79.

242. Shirakawa T., Li A., Dubowitz M. Association between atopy and variants of the beta subunit of the high-affinity immunoglobulin E receptor // Nat. Genet. – 1994. - № 7. – P. 125-129.

243. Shirakawa T., Mao X.Q., Sasaki S. et al. Association between atopic asthma and a coding variant of Fc epsilon RI beta in a Japanese population [letter] // Hum. Molecular Genet. – 1996. - № 5. – P. 2068.

244. Sipes I.G., Gandolfi A.J. Biotransformation of toxicants // Casarett and Doull’s toxicology. – N. Y.: Macmillan Publishing Company. -1986. – P. 99-173.

245. Skadhauge L. R., Christens K., Kyvik K. O. et al. Genetic and environmental influence on asthma: a population-based study of 11,688 Danish twin pairs // Eur. Respir. J. – 1999. – V. 13. – P. 8-14.

246. Sodhi C.P., Rana S.V., Mehta S. Study of oxidative stress in rifampicin induced hepatic injury in growing rats with and without protein energy malnutrition // Hum. Exp. Toxicol. – 1997. - № 20. – P. 315-321.

247. Sodhi C.P., Rana S.V., Mehta S.K. et al. Study of oxidative stress in izoniazid induced hepatic injury in young rats with and without protein energy malnutrition // J. Biochem. Toxicol. – 1996. - № 11. – P. 139-146.

248. Spielman R.S., McGunis R.E., Ewens W.J. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes-mellitus (IDDM) // Am. J. Hum. Genet. – 1993. – V. 52. – P. 506-516.

249. Spitx M.R., Duphrone C.M., Detry M.A. et al. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk // Cancer Epidemiology, Biomarkers & Prevention. – 2000. - V. 9. – P. 1017-1020.

250. Spurdle A.B., Chen X., Abbazadegan M. et al. CYP17 promoter polymorphism and ovarian cancer risk // Int. J. Cancer. – 2000. - V. 86. – P. 436-439.

251. Stead W.W. Genetics and resistance to tuberculosis: could resistance be enhanced by genetics engineering? // Ann. Int. Med. – 1992. – V. 116. – P. 937-941.

252. Steele M.A., Burk R.F., Desprez R.M. et al. Toxic hepatitis with isoniazid and rifampicin – a meta analysis // Chest. – 1991. - № 99. – P. 465-471.

253. Sterk P.J., Fabbri L.M., Quanjer P.H. et al. Airway responsiveness // Eur. Respir. J. – 1993. – V. 6. Suppl. – P. 55-64.

254. Strachan D.P. Hayfever, hygiene, and household size // Biol.Med.J. – 1989. - V. 299. - P. 1259-1260.

255. Sugimura H., Suzuki I., Hamada G.S. et al. Cytochrome P450 IAI genotype in lung cancer patients and controls in Rio de Janeiro, Brazil // Cancer Epidemiol. Biomarkers and Prev. – 1994. - № 3. – P. 145-148.

256. Summerhill E., Levitt S. A., Gidley H. et al. Beta(2)-adrenergic receptor Arg16/Arg16 genotype is associated with reduced lung function, but not with asthma, in the Hutterites // Am. J. Respir. Crit Care Med. – 2000. – V. 162. – P. 599-602.

257. Surry D.D., Neneses-Lorente G., Heavens R. et al. Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A, and 4A1 // Xenobiotica. - 2000. – V. 30. - № 5. – P. 441-456.

258. Tamer L., Calikoglu M., Ates N. A. et al. Glutathione S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma // Respirology. – 2004. – V. 9. - № 4. – P. 493-498.

259. Tanaka K., Sugiura H., Uehara M. et al. Association between mast cell chymase genotype and atopic eczema: alone and those with atopic eczema and atopic respiratory disease // Clin. Exp. Allergy. – 1999. – V. 29. – P. 800-803.

260. The Collaborative Study in the Genetics of Asthma. A genome-wide search for allergic response (atopy) genes in three ethnic groups // Hum. Genet. – 2004. - V. 114. - P. 157-164.

261. The Collaborative Study on the Genetics of Asthma. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. // Nat. Genet. – 1997. – V. 15. – P. 389-392.

262. Thomas N.S., Wilkinson J., Holgate S.T. The candidate region approach to the genetics of asthma and allergy. // Am. J. Respir. Crit Care Med. – 1997. – V. 156. – P. 144-151

263. To-Figueras J., Gene M., Gomez-Catalan J. Glutathione-S-transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lang cancer susceptibility // Cancer Epidemiol. Biomark. Prev. – 1996. - V. 5. – P. 337-342.

264. Urs A. Molecular mechanisms of genetic polymorphisms of drug metabolism // Annu. Rev. Pharmacol. Toxicol. – 1997. – V. 37. – P. 169-196.

265. Van der Pouw Kraan T.C., Van Veen A., Boeije L.C. et al. An IL13 promoter polymorphism associated with increased risk of allergic asthma // Gene Immun. – 1999. - № 1. – P. 61-65.

266. Von Hertzen L., Klaukka T., Mattila H. et al. Mycobacterium tuberculosis infection and the subsequent development of asthma and allergic conditions // J. Allergy Clin. Immunol. – 1999. – V. 104. - № 6. – P. 1211-1214.

267. Von Mutius E., Martinez F. D., Fritzsch C. et al. Prevalence of asthma and atopy in two areas of West and East Germany // Am. J. Respir. Crit. Care Med. – 1994. – V. 149. - № 2. – P. 358-364.

268. Watanabe J., Hayashi S., Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5’-flanking region // J. Biochem. – 1994. – V. 116. – P. 321-326.

269. Watson M. A., Stewart R. K., Smith G. B. J. et al. Human glutathione S-transferase P1 polymorphism: relationship to lung tissue enzyme activity and population freguency distribution // Carcinogenesis. – 1998. – V. 19. – P. 275-280.